Economic Times has profiles of 3 new VC-backed Life sciences companies:
FOUNDED: 2005
INVESTOR: Artiman VenturesACTIVITY: Drug discovery using a proprietary computer simulation platform to find new uses for old drugs in inflammation and cancer
POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing,selling its proprietary green chemistry technology to various industries
FOUNDED: 2010
ACTIVITY: Researching drugs for wound healing,skin pigmentation,finding new uses for old drugs in dandruff and acne treatments
INVESTOR: Navam Capital
POTENTIAL REVENUE STREAMS: Licensing drugs for development and marketing to larger companies
FOUNDED: 2009
INVESTOR: Kitven,Accel Partners,India Innovation Fund
ACTIVITY: Diagnostics to personalise cancer medicine in partnership with hospitals and drug companies
POTENTIAL REVENUE STREAMS: Offering testing services to cancer hospitals to match drugs to patients,partnering drug companies during clinical trials
Arun Natarajan is the Founder & CEO of Venture Intelligence, the leading provider of data and analysis on private equity, venture capital and M&A deals in India. View free samples of Venture Intelligence newsletters and reports. Email the author at [email protected]
